On April 5, 2024, Xinnuo Wei disclosed in the interactive trading of the Shenzhen Stock Exchange that as of March 29, 2024, the number of shareholders of the company was 19,000, a decrease of 396 or 2.04% from the previous period (March 20, 2024).
The number of shareholders is lower than the industry average. According to Choice data, as of March 29, 2024, the average number of shareholders of listed companies in the pharmaceutical and biotechnology industry is 34,700. Among them, the number of shareholders of the company is in the range of 5,000~15,000, accounting for the highest proportion, 29.46%.
Distribution of the number of shareholders in the pharmaceutical and biological industry
Number of shareholders and share price
Since February 20, 2024, the number of shareholders of the company has decreased for 4 consecutive periods, and the decrease so far is 18.85%. From February 20, 2024 to March 29, 2024, the stock price increased by 21.35%.
Number of shareholders and share price
Number of shareholders and share capital
As of March 29, 2024, the company's latest total share capital is 1.171 billion shares, of which the outstanding share capital is 1.039 billion shares. The average number of outstanding shares held by households increased from 53,500 shares in the previous period to 54,600 shares, and the average market value of households was 2,019,100 yuan.
The average amount of shares held by each household
The market value of circulating accounts held by Xinnovo households is higher than the industry average. According to Choice data, as of March 29, 2024, the average market value of A-share listed companies in the pharmaceutical and biological industry is 412,900 yuan. Among them, 25.10% of the company's households hold a circulating stock market value in the range of 140,000~270,000.
Distribution of per capita circulating market value of the pharmaceutical and biological industry
SZSE shareholdings
On March 29, 2024, the number of shares held by SZSE was 16,122,300 shares, accounting for 1.37% of the outstanding share capital, an increase of 2.82% from 15,679,600 shares in the previous period (March 20, 2024).
SZSE shareholding chart
Disclaimer: This article is based on big data and is for reference only and does not constitute any investment advice.